WESTON, FL, Aug. 24, 2016 /PRNewswire/ - Apotex Corp. announced today that it has re-entered the market with Paroxetine Controlled-Release Tablets, the authorized generic version of Paxil CR®.
Apotex's Paroxetine Controlled-Release Tablets, manufactured by GSK, are available in 12.5mg, 25mg and 37.5mg strengths. According to IMS Health, Paxil CR® had approximately $126 million in sales in the 12 months ending in June 2016.
Re-entering the market with Paroxetine Controlled-Release Tablets is just another example of how Apotex is everywhere. Making a difference. One life at a time.
Apotex Inc. is the 7th largest generic pharmaceutical company globally (according to IMS Health) with over 10,000 employees and estimated sales of approximately $2 billion. The company's US headquarters is based in Weston, Florida. With its worldwide manufacturing sites, Apotex can produce up to 24 billion dosages per year. It produces 300 medicines in 4,000 dosages and formats that are exported to 120 countries. It has 300 products under development and will spend $2 billion over the next 10 years on research and development.
*Paxil CR is a registered trademark of GLAXOSMITHKLINE LLC.
For more information:
Last updated on: 27/08/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.